The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling
Author
Alasady, Milad JTerry, Alexander R
Pierce, Adam D
Cavalier, Michael C
Blaha, Catherine S
Adipietro, Kaylin A
Wilder, Paul T
Weber, David J
Hay, Nissim
Date
2021-08-19Journal
PLoS ONEPublisher
Public Library of ScienceType
Article
Metadata
Show full item recordAbstract
S100B is frequently elevated in malignant melanoma. A regulatory mechanism was uncovered here in which elevated S100B lowers mRNA and secreted protein levels of interleukin-6 (IL6) and inhibits an autocrine loop whereby IL6 activates STAT3 signaling. Our results showed that S100B affects IL6 expression transcriptionally. S100B was shown to form a calcium-dependent protein complex with the p90 ribosomal S6 kinase (RSK), which in turn sequesters RSK into the cytoplasm. Consistently, S100B inhibition was found to restore phosphorylation of a nuclear located RSK substrate, CREB, which is a potent transcription factor for IL6 expression. Thus, elevated S100B reduces IL6-STAT3 signaling via RSK signaling pathway in malignant melanoma. Indeed, the elevated S100B levels in malignant melanoma cell lines correspond to low levels of IL6 and p-STAT3.Keyword
autocrine loopS100B
Interleukin 6--antagonists & inhibitors
Melanoma
STAT3 Transcription Factor
Identifier to cite or link to this item
http://hdl.handle.net/10713/16490ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0256238